A New Clinical Trial (IMAGE)
Caption
A major grant from the Alzheimer's Association will enable researchers to test a drug that could reduce brain inflammation in Alzheimer's patients and possibly slow the progression of the disease. John Sedivy (right), a professor of molecular biology, cell biology and biochemistry at Brown University and director of the Brown Center on the Biology of Aging, and Dr. Stephen Salloway (left), a professor of neurology and psychiatry at the Warren Alpert Medical School and director of Butler Hospital's Memory and Aging Program, will lead the research
Credit
David DelPoio/Brown University
Usage Restrictions
None
License
Licensed content